Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for managing type 2 diabetes, with some now also approved for weight management
Its mechanism of action mimics a hormone called GLP-1, which regulates blood sugar and appetite
And although Ozempic and Mounjaro have been cleared by the FDA to help with the condition, it has not been approved as a weight loss option, though similar GLP-1 drugs such as semaglutide (Wegovy) and liraglutide (Saxenda) have been approved by the FDA to help treat obesity
How Does Semaglutide Work to Reduce Appetite and Support Weight Loss
What makes Mounjaro/tirzepatide unique is that its a dual agonist it activates two hormones, GLP-1 and GIP , that help regulate appetite and blood sugar
US$ 24.33
US$ 22.43
US$ 23.10
